Analyses / XOM
Mixed read: shares sit in the upper-middle of their 52-week range, but revenue and EPS are contracting per provider data.
A free account reveals XOM's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
Shares trade about 62% of the way up the 52-week range, well above the 114.19 low. Trailing P/E is 16.4x, EV/EBITDA 11.9x, dividend yield 2.52% with a 59.7% payout, and beta 0.19 (low sensitivity to the broad market). Provider five-year revenue growth is 12.65%. In the provider insider sample, shares bought (1,051,335) far exceed shares sold (150,164). If revenue growth turns positive from -6.69%, the trailing multiple could look less stretched.
▼ Bear Case
Revenue growth is -6.69% and EPS growth is -20.34%. Forward P/E of 23.1x sits above trailing 16.4x, which implies the market expects lower earnings. Price-to-FCF of 28.2x is elevated. Shares fell 3.97% on the day to 160.58, below the 167.21 prior close and near the 160.55 session low. ROE, ROIC, debt-to-equity and RSI are unavailable, so balance-sheet and momentum checks are incomplete.
Valuation
FAIRLY PRICED — score 52/100
Trailing multiples look moderate, but forward P/E and price-to-FCF are higher, and earnings and revenue are falling.
Technical Levels
Support · $160.55 (Session low) · $154.00 (Scenario entry floor) · $114.19 (52-week low)
Resistance · $167.21 (Prior close) · $166.96 (Session high) · $188.50 (52-week high)
RSI: unavailable
Financial Health
Score 55/100. Liquidity ratios are adequate but not strong. Debt and coverage data are missing, so solvency cannot be fully assessed.
Catalysts
| No dated earnings or company event in the payload | unknown | unknown |
| Insider and ETF flow headlines in recent news | recent | low |
Risk Flags
See XOM's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock XOM free →Recent News
- Should You Buy Occidental Stock For Its Cash Flow?Yahoo
- ETFs Are Buying ExxonMobil (XOM) on Nov. 17Yahoo
- ExxonMobil (XOM) Just Achieved Something 95% of S&P 500 (GSPC) Members Haven't DoneYahoo
- Helmerich & Payne, Inc. Announces Fiscal Fourth Quarter and Fiscal 2026 ResultsYahoo
- What Drove Venture Global's 69% EBITDA Jump?Yahoo
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full XOM analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
XOM FAQ
Is XOM a buy right now?
Exxonmobil Holdings Corp's current read is a Recovery / value-leaning, with a weak earnings trend setup with medium confidence over a 1-3 months horizon. Valuation: FAIRLY PRICED. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is XOM overvalued?
FAIRLY PRICED (valuation score 52/100). Trailing multiples look moderate, but forward P/E and price-to-FCF are higher, and earnings and revenue are falling.
What are the risks of buying XOM?
Revenue growth is -6.69% and EPS growth is -20.34%. Forward P/E of 23.1x sits above trailing 16.4x, which implies the market expects lower earnings. Price-to-FCF of 28.2x is elevated. Shares fell 3.97% on the day to 160.58, below the 167.21 prior close and near the 160.55 session low. ROE, ROIC, debt-to-equity and RSI are unavailable, so balance-sheet and momentum checks are incomplete.